Dudediligence.

Vir Biotechnology, Inc

VIRNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price
FilingsNewest: 8-K, Director or officer changeOct 1 →InsidersNo open-market buys. 10 insiders sold $18.0M, all 49 sales on a 10b5-1 plan.→HoldersBlackRock 12.2%ARCH Venture 7.5%Vanguard Portfolio 6.8%→Financing →PeersClosest companies: DNLI, JANX, STRO→

From the filings

Figures

Revenue
$303.2Mlast 12 months
Net income
−$251.7Mlast 12 months
Operating cash flow
−$446.1Mlast 12 months
Cash and equivalents
$278.7Mat the last balance sheet
Shares outstanding
169.2M shareson issue
Every year and quarter →